Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Maruhn

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Arzneimittel-Forschung|October 1, 1986
Pharmacokinetics of ciprofloxacin. 1st communication: absorption, concentrations in plasma, metabolism and excretion after a single administration of [14C]ciprofloxacin in albino rats and rhesus monkeysH M Siefert, D Maruhn, W Maul, et al.
Zeitschrift Fur Kreislaufforschung|January 1, 1972
[Plasma enzyme activities and morphology of the myocardium following acute experimental coronary occlusion in relation to the spontanous collateral vessels of the heart]F W Schulz, W Meesmann, J Tüttemann, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1971
[Early effects of acute experimental coronary occlusion on plasma enzymes and heart morphology in relation to spontaneous collaterals of the heart]F W Schulz, W Meesmann, D Maruhn, et al.
Der Radiologe|September 1, 1984
[Enzyme determination in the urine for the evaluation of kidney tolerance of the water-soluble roentgen contrast medium iopamidol]H G Hartmann, G A Jutzler, R Bambauer, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1974
[Urine lactate dehydrogenase, N-acetyl-beta-D-glucosaminidase and trehalase excretion in primary hypertension and various kidney diseases]L Gielow, D Maruhn, I Fuchs, et al.
International Journal of Clinical Pharmacology and Therapeutics|July 31, 2009
Randomized, crossover, single-blind, placebo-controlled, human pharmacology clinical trial with desoxypeganine, a new cholinesterase and selective MAO-A inhibitor: multiple-dose pharmacokineticsJ Algorta, M A Pena, A Alvarez, et al.
Methods and Findings in Experimental and Clinical Pharmacology|June 19, 2008
Phase I clinical trial with desoxypeganine, a new cholinesterase and selective MAO-A inhibitor: tolerance and pharmacokinetics study of escalating single oral dosesJ Algorta, M A Pena, C Maraschiello, et al.
Zentralblatt Fur Bakteriologie, Mikrobiologie Und Hygiene. 1. Abt. Originale B, Hygiene|January 1, 1982
Comparison of the morphological alteration and disintegration test (MADT) and the chimpanzee infectivity test for determination of hepatitis B virucidal activity of chemical disinfectantsO Thraenhart, E K Kuwert, N Scheiermann, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Arzneimittel-Forschung|October 1, 1986
Pharmacokinetics of ciprofloxacin. 1st communication: absorption, concentrations in plasma, metabolism and excretion after a single administration of [14C]ciprofloxacin in albino rats and rhesus monkeysH M Siefert, D Maruhn, W Maul, et al.
Zeitschrift Fur Kreislaufforschung|January 1, 1972
[Plasma enzyme activities and morphology of the myocardium following acute experimental coronary occlusion in relation to the spontanous collateral vessels of the heart]F W Schulz, W Meesmann, J Tüttemann, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1971
[Early effects of acute experimental coronary occlusion on plasma enzymes and heart morphology in relation to spontaneous collaterals of the heart]F W Schulz, W Meesmann, D Maruhn, et al.
Der Radiologe|September 1, 1984
[Enzyme determination in the urine for the evaluation of kidney tolerance of the water-soluble roentgen contrast medium iopamidol]H G Hartmann, G A Jutzler, R Bambauer, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1974
[Urine lactate dehydrogenase, N-acetyl-beta-D-glucosaminidase and trehalase excretion in primary hypertension and various kidney diseases]L Gielow, D Maruhn, I Fuchs, et al.
International Journal of Clinical Pharmacology and Therapeutics|July 31, 2009
Randomized, crossover, single-blind, placebo-controlled, human pharmacology clinical trial with desoxypeganine, a new cholinesterase and selective MAO-A inhibitor: multiple-dose pharmacokineticsJ Algorta, M A Pena, A Alvarez, et al.
Methods and Findings in Experimental and Clinical Pharmacology|June 19, 2008
Phase I clinical trial with desoxypeganine, a new cholinesterase and selective MAO-A inhibitor: tolerance and pharmacokinetics study of escalating single oral dosesJ Algorta, M A Pena, C Maraschiello, et al.
Zentralblatt Fur Bakteriologie, Mikrobiologie Und Hygiene. 1. Abt. Originale B, Hygiene|January 1, 1982
Comparison of the morphological alteration and disintegration test (MADT) and the chimpanzee infectivity test for determination of hepatitis B virucidal activity of chemical disinfectantsO Thraenhart, E K Kuwert, N Scheiermann, et al.
Pageof 4